Clinical Trials Logo

Clinical Trial Summary

Preoperative administration of pregabalin would reduce the end tidal concentration of sevoflurane during laparoscopic cholecystectomy with added beneficial improving of the quality of postoperative analgesia.


Clinical Trial Description

laparoscopic cholecystectomy is a painful and stressful surgical procedure. Pregabalin is a lipophilic structural analogue of the inhibitory γ-aminobutyric acid by binding to the presynaptic voltage-gated calcium channels that are widely distributed throughout the central and peripheral nervous system. Pregabalin has anticonvulsant, anxiolytic, sleep-modulating, anti-hyperalgesic, opioid-sparing6 and anti-allodynic properties through inhibition of the release of excitatory neurotransmitters such as glutamate, norepinephrine, serotonin, dopamine and substance P. These unique characteristics make pregabalin as a useful therapeutic for treating neuropathic pain and acute postoperative pain in several models of incisional injury and inflammatory conditions including laparoscopic cholecystectomy. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01571804
Study type Interventional
Source Mansoura University
Contact
Status Completed
Phase Phase 2
Start date December 2011
Completion date March 2012

See also
  Status Clinical Trial Phase
Active, not recruiting NCT06069557 - The Effect of Respiratory Exercises on Abdominal Distension in Laparoscopic Cholecystectomy Patients N/A
Recruiting NCT06343753 - Quality of Recovery After Laparoscopic Cholecystectomy Comparing Opioid Free Analgesia Versus Opioid Free Anesthesia N/A
Completed NCT02031510 - Dexmedetomidine in Transversus Abdominis Plane Block for Laparoscopic Cholecystectomy Phase 1/Phase 2